GRINDWELL2023-04-012023-06-30 GRINDWELL2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member GRINDWELL2023-06-30 GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue01Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue02Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue03Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue04Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults01Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults02Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults03Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults04Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets01Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets02Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets03Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets04Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member GRINDWELL2023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities02Member GRINDWELL2023-06-30in-bse-fin:OneReportableSegmentLiabilities02Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities03Member GRINDWELL2023-06-30in-bse-fin:OneReportableSegmentLiabilities03Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities04Member GRINDWELL2023-06-30in-bse-fin:OneReportableSegmentLiabilities04Member GRINDWELL2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 506076 GRINDWELL NOTLISTED Grindwell Norton Limited Equity 2023-04-01 2024-03-31 2023-08-14 2023-07-31 INR Lakhs First quarter 12:30:00 14:05:00 2023-08-14 2023-08-14 Not applicable Multi segment 2023-04-01 2023-06-30 Unaudited Standalone 6600900000.00 146000000.00 6746900000.00 2344800000.00 749200000.00 -88800000.00 789300000.00 19300000.00 164100000.00 1468400000.00 5446300000.00 1300600000.00 0.00 1300600000.00 329700000.00 -100000.00 329600000.00 0.00 971000000.00 0.00 0.00 0.00 0.00 971000000.00 -3500000.00 967500000.00 0.00 0.00 553600000.00 5 8.77 8.77 0.00 0.00 8.77 8.77 1. The above Unaudited Standalone Financial Results for the quarter ended June 30, 2023 (financial results) have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on August 14, 2023. The Statutory Auditors of the Company have carried out a limited review of the above financial results. These financial results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, as amended. 2. The financial results are prepared in accordance with the Indian Accounting Standard 34 'Interim Financial Reporting' (Ind AS - 34), as prescribed under Section 133 of the Companies Act, 2013, read with the relevant Rules issued thereunder and other accounting principles generally accepted in India. 3. During the quarter ended June 30, 2022, the Company had acquired 100% equity shares of PRS Permacel Private Limited (PRS) for a consideration of Rs. 121,12 Lakhs. Subsequently, pursuant to a Scheme of Amalgamation of PRS with the Company, duly approved by the National Company Law Tribunal (NCLT), vide its order dated June 22, 2023, all the assets and liabilities of PRS at fair value were transferred to and vested in the Company with effect from May 27, 2022, being the appointed date. The excess of consideration paid over and above the fair value of the assets and liabilities taken over amounting to Rs. 46,30 lakhs have been accounted as Goodwill. The Company is in the process of meeting the regulatory requirements as prescribed under the NCLT order. Accordingly, the figures for the previous periods have been restated to give effect to the Scheme of Amalgamation. The key information pertaining to the previous periods before giving effect to the said Scheme and as published earlier were as under: (Rs. in Lakhs) Quarter ended Particulars 31-03-2023 30-06-2022 31-03-2023 (Refer Note 5) (Unaudited) (Audited) Total Income 63,711 62,685 2,42,005 Total Expenses 50,437 50,379 1,95,087 Tax expens 3,386 3,150 11,849 Net Profit for the period 9,888 9,156 35,069 Other comprehensive income, net of income tax 1,065 (62) 688 Earnings per equity share (in Rs.) 8.93 8.27 31.67 4. The Segment wise information as required by Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended is furnished in Annexure I. 5. The figures for the quarter ended March 31 , 2023 are the balancing figures between audited figures in respect of the full financial year ended March 31 , 2023 and the published year to date figures upto third quarter of the previous financial year. 6. The financial results are available on the SSE Limited website, www.bseindia.com, National Stock Exchange of India Limited website,www.nseindia.com and on the Company's website, www.grindwellnorton.co.in Other Expenses 1468400000.00 Abrasives 3255400000.00 Ceramics & Plastics 2734100000.00 Digital Services 505200000.00 Others 140600000.00 6635300000.00 34400000.00 6600900000.00 Abrasives 447700000.00 Ceramics & Plastics 543600000.00 Digital Services 194000000.00 Others 30300000.00 1215600000.00 19200000.00 -104200000.00 1300600000.00 Abrasives 7308900000.00 Ceramics & Plastics 6991000000.00 Digital Services 788200000.00 Others 439600000.00 15527700000.00 9975600000.00 25503300000.00 Abrasives 2523600000.00 Ceramics & Plastics 2528100000.00 Digital Services 580200000.00 Others 279600000.00 5911500000.00 577000000.00 6488500000.00 Remeasurement of post employment benefitsobligations -4600000.00 -4600000.00 -1100000.00 0.00